-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MPZQwiVee5HfwPTl7OS8rUfQ5lPeBN2tFimgMKeonXGbJovIG3+QqUc4biLs7Ca1 vO2cyY1cN1F0JIH9Fn7Qog== 0000950133-01-000489.txt : 20010213 0000950133-01-000489.hdr.sgml : 20010213 ACCESSION NUMBER: 0000950133-01-000489 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-57843 FILM NUMBER: 1534088 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 SC 13G/A 1 w45440sc13ga.txt AMENDMENT NO. 1 TO SCHEDULE 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)(1) United Therapeutics Corporation (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 91307C 10 2 (CUSIP Number) December 31, 2000 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - ------------------ (1)The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities and Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 - --------------------------- ------------------------- CUSIP NO. 91307C 10 2 13G PAGE 2 OF 6 PAGES - --------------------------- ------------------------- - ---------------------------------------------------------------------------------------------- NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 1 Martine A. Rothblatt - ---------------------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ] 2 (b)[ ] - ---------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ---------------------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 4 United States of America - ---------------------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF SHARES 1,728,828 -------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY EACH --------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER 1,728,828 --------------------------------------------------------------- PERSON WITH 8 SHARED DISPOSITIVE POWER 0 - ----------------------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 1,728,828 - ----------------------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - ----------------------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.57% - ----------------------------------------------------------------------------------------------- TYPE OF REPORTING PERSON* 12 IN ===============================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT! 3 - --------------------------- ------------------------- CUSIP NO. 91307C 10 2 13G PAGE 3 OF 6 PAGES - --------------------------- -------------------------
ITEM 1(a). NAME OF ISSUER: United Therapeutics Corporation ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 1110 Spring Street Silver Spring, MD 20910 ITEM 2(a). NAME OF PERSON FILING: Martine A. Rothblatt ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 1110 Spring Street Silver Spring, MD 20910 ITEM 2(c). CITIZENSHIP: United States of America ITEM 2(d). TITLE OF CLASS OF SECURITIES: This statement relates to the shares of common stock, par value $0.01 per share (the "Common Stock"), of United Therapeutics Corporation, a Delaware corporation (the "Company"), together with the associated preferred stock purchase rights attached to the Common Stock. ITEM 2(e). CUSIP NUMBER: 91307C 10 2 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [ ] Insurance company as defined in Section 3(a) (19) of the Exchange Act. 4 - --------------------------- ------------------------- CUSIP NO. 91307C 10 2 13G PAGE 4 OF 6 PAGES - --------------------------- -------------------------
(d) [ ] Investment company registered under Section 8 of the Investment Company Act. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [ ] Group, in accordance with Rule 13d-1(b)(1) (ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [ ] ITEM 4. OWNERSHIP. (a) Amount beneficially owned: 1,728,828 shares, which includes 17,660 shares held by reporting person's children, 370,324 shares held by reporting person's spouse (the beneficial ownership of which the reporting person disclaims), 595,665 shares that may be acquired upon exercise of certain options held by reporting person, and 128 shares that may be acquired upon exercise of certain options held by reporting person's spouse (the beneficial ownership of which the reporting person disclaims). (b) Percent of class: 8.57% (c) Number of shares as to which such person had voting power: (i) Sole power to vote or to direct the vote: 1,728,828 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 1,728,828 5 - --------------------------- ------------------------- CUSIP NO. 91307C 10 2 13G PAGE 5 OF 6 PAGES - --------------------------- -------------------------
(iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. None. ITEM 10. CERTIFICATION. None required. Reporting person filed pursuant to Rule 13d-1(d). 6 - --------------------------- ------------------------- CUSIP NO. 91307C 10 2 13G PAGE 6 OF 6 PAGES - --------------------------- -------------------------
SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 2001 ------------------------------------ /s/ Martine A. Rothblatt ------------------------------------ Martine A. Rothblatt -----END PRIVACY-ENHANCED MESSAGE-----